Harrow Health Inc expected to post a loss of 4 cents a share - Earnings Preview

Harrow

01/05/2023 12:52

* Harrow Health Inc  HROW.OQ   HROW.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 11. 
    * The Nashville Tennessee-based  company is expected to
report  a
13.0% increase in revenue to $24.987 million from $22.12 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harrow Health Inc
is for
a loss of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harrow
Health Inc
is $25.6​, above​ its last closing price of $25.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.15       -0.12      0.04      Beat    134.3
 Sep. 30 2022  -0.01       0.00       -0.24     Missed  -9,500
 Jun. 30 2022  -0.03       -0.01      -0.23     Missed  -3,348
                                                        .3​
 Mar. 31 2022  -0.03       -0.03      0.03      Beat    185.7
 ​​Dec.        -0.04       -0.04      -0.27     Missed  -535.3
 31 2021                                                
 Sep. 30 2021  -0.02       -0.02      -0.31     Missed  -1,140
                                                        ​
 Jun. 30 2021  -0.03       -0.03      -0.09     Missed  -200
 Mar. 31 2021  -0.04       -0.03      0.01      Beat    128.6
 This summary was machine generated May 1 at 11:52 GMT.  All
figures in US dollars  unless otherwise stated